SARS CoV 2 News and Research

RSS

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

27 Sep 2020

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

As we improve our understanding of immune responses and correlates of protection against the severe acute respiratory syndrome coronavirus (SARS-CoV-2), two UK researchers emphasize that we will probably utilize different assays to tackle specific questions. Their commentary is published in the prestigious journal Lancet Infectious Diseases.

27 Sep 2020

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Yale has designated three independent laboratories to perform the university-developed SalivaDirectTM COVID-19 test.

26 Sep 2020

Combination of heat and high relative humidity can disinfect N95 mask materials

As the COVID-19 pandemic swept around the world early this year, shortages of protective equipment such as N95 masks left healthcare workers little choice but to reuse the masks they had - increasing the risk of infection for both them and their patients.

26 Sep 2020

Mask-wearing, handwashing, and social distancing protect against COVID-19, confirms study

A contact tracing study presented at this year's ESCMID Conference on Coronavirus Disease (ECCVID) confirms the effectiveness of wearing of masks in public, handwashing, and social distancing to protect against SARS-CoV-2 infection.

26 Sep 2020

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online) shows that a shorter time from symptom onset to hospitalization is associated with more serious disease and death in patients with COVID-19.

26 Sep 2020

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Analysis of samples taken to test for respiratory viruses over the past five years suggests that the emergence of SARS-CoV-2 was associated with a large drop in circulation of other common respiratory viruses during the first wave.

26 Sep 2020

New trial tests combination antibody treatment for preventing COVID-19 illness

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston.

25 Sep 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

A mix of ultrapotent antibodies from recovered COVID-19 patients has been shown to recognize and lock down the infection machinery of the pandemic coronavirus and keep it from entering cells. Each of the antibody types performs these overlapping tasks slightly differently.

25 Sep 2020

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.

25 Sep 2020

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

Persons with critical corona-disease may have antibodies blocking the body´s most important defence mechanisms.

25 Sep 2020

D614G mutation now the dominant variant in the global COVID-19 pandemic

Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.

25 Sep 2020

Inflammation in the eye after COVID-19

A new study published on the preprint server medRxiv shows the occurrence of ocular pathology in the period of recovery following COVID-19. This throws more light on the occurrence of inflammation in people recovering from COVID-19.

25 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.

25 Sep 2020

SARS CoV 2 News and Research

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Combination of heat and high relative humidity can disinfect N95 mask materials

Mask-wearing, handwashing, and social distancing protect against COVID-19, confirms study

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

New trial tests combination antibody treatment for preventing COVID-19 illness

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

D614G mutation now the dominant variant in the global COVID-19 pandemic

Inflammation in the eye after COVID-19

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Individuals with severe forms of COVID-19 disease can have compromised type I interferon responses

New experiments reveal how viruses initiate translation of genetic material into proteins

New study may explain why more men than women die from COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News